Ludwig Maximilians Universitt Mnchen competitive analysis

Loading summary...

Explore Ludwig Maximilians Universitt Mnchen's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of Cancer10

Latest publications and patents of Ludwig Maximilians Universitt Mnchen New

Explore the latest publications and patents granted to Ludwig Maximilians Universitt Mnchen, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Ludwig Maximilians Universitt Mnchen

Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerRevoked

Latest PTAB cases involving Ludwig Maximilians Universitt Mnchen

Discover the latest PTAB cases involving Ludwig Maximilians Universitt Mnchen, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ludwig Maximilians Universitt Mnchen with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LUDWIG MAXIMILIANS UNIVERSITT MNCHEN - 10 - -
ABBVIE109 - 1
BOEHRINGER INGELHEIM RCV BOEHRINGER INGELHEIM7 - - -
DR H ULRICH DORRIES26 - - -